Protective action of CLA against oxidative inactivation of paraoxonase 1, an antioxidant enzyme

Lipids

Volumn 38, Issue 6, 2003, Pages 615-622

  Su, Nguyen Duy ^a   Liu, Xi Wen ^a   Kim, Mee Ree ^a   Jeong, Tae Sook ^b   Sok, Dai Eun ^a  

^a Chungnam National University   (South Korea)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANTS; CALCIUM; FATTY ACIDS; HYDROGEN PEROXIDE; ISOMERS; OXIDATION;

OXIDATIVE INACTIVATION;

ENZYMES;

ANTIOXIDANT; ARYLDIALKYLPHOSPHATASE; LINOLEIC ACID; OLEIC ACID; PROTEIN; PROTEIN CLA; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME STABILITY; HUMAN; OXIDATIVE STRESS; PROTEIN BINDING;

ANTIOXIDANTS; ARYLDIALKYLPHOSPHATASE; ASCORBIC ACID; BENZENE DERIVATIVES; COPPER; HUMANS; HYDROGEN PEROXIDE; HYDROXYMERCURIBENZOATES; ISOMERISM; LINOLEIC ACIDS, CONJUGATED; OXIDATION-REDUCTION;

EID: 0042624747     PISSN: 00244201     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11745-003-1106-9     Document Type: Article

References (45)

1. Fritsche, J., and Steinhart, H. (1998) Analysis, Occurrence and Physiological Properties of trans Fatty Acids (TFA) with Particular Emphasis on Conjugated Linoleic Acid Isomers (CLA) - A Review, Fett/Lipid 100, 190-210.
2. Ha, Y.L., Grim, N.K., and Pariza, M.W. (1987) Anticarcinogens from Fried Ground Beef: Heat-Altered Derivatives of Linoleic Acid, Carcinogenesis 8, 1881-1887.
3. Ip, C. (1997) Review of the Effects of trans Fatty Acids, Oleic Acid, n-3 Polyunsaturated Fatty Acids, and Conjugated Linoleic Acid on Mammary Carcinogenesis in Animals, Am. J. Clin. Nutr. 66, 1523S-1529S.
4. Cesano, A., Visonneau, S., Scimeca, J.A., Kritchevsky, D., and Santoli, D. (1998) Opposite Effects of Linoleic Acid and Conjugated Linoleic Acid on Human Prostatic Cancer in SCID Mice, Anticancer Res. 18, 1429-1434.
5. Park, Y., Albright, K.J., Liu, W., Storkson, J.M., Cook, M.E., and Pariza, M.W. (1997) Effect of Conjugated Linoleic Acid on Body Composition in Mice, Lipids 32, 853-858.
6. West, D.B., Delany, J.P., Camet, P.M., Blohm, F., Truett, A.A., and Scimeca, J. (1998) Effects of Conjugated Linoleic Acid on Body Fat and Energy Metabolism in the Mouse, Am. J. Physiol. 275, 667-672.
7. DeLany, J.P., Blohm, F., Truett, A.A., Scimeca, J.A., and West, D.B. (1999) Conjugated Linoleic Acid Rapidly Reduces Body Fat Content in Mice Without Affecting Energy Intake, Am. J. Physiol. 276, 1172-1179.
8. Ostrowska, E., Muralitharan, M., Cross, R.F., Bauman, D.E., and Dunshea, F.R. (1999) Dietary Conjugated Linoleic Acids Increase Lean Tissue and Decrease Fat Deposition in Growing Pigs, J. Nutr. 129, 2037-2042.
9. Lee, K.N., Kritchevsky, D., and Pariza, M.W. (1994) Conjugated Linoleic Acid and Atherosclerosis in Rabbits, Atherosclerosis 108, 19-25.
10. Nicolosi, R.J., Rogers, E.J., Kritchevsky, D., Scimeca, J.A., and Huth, P.J. (1997) Dietary Conjugated Linoleic Acid Reduces Plasma Lipoproteins and Early Aortic Atherosclerosis in Hypercholesterolemic Hamsters, Artery 22, 266-277.
11. Kritchevsky, D., Tepper, S.A., Wright, S., Tso, P., and Czarnecki, S.K. (2000) Influence of Conjugated Linoleic Acid (CLA) on Establishment and Progression of Atherosclerosis in Rabbits, J. Am. Coll. Nutr. 19, 472S-477S.
12. Cook, M.E., Miller, C.C., Park, Y., and Pariza, M.W. (1993) Immune Modulation by Altered Nutrient Metabolism: Nutritional Control of Immune-Induced Growth Depression, Poult. Sci. 72, 1301-1305.
13. Wong, M.W., Chew, B.P., Wong, T.S., Hosick, H.L., Boylston, T.D., and Shultz, T.D. (1997) Effects of Dietary Conjugated Linoleic Acid on Lymphocyte Function and Growth of Mammary Tumors in Mice, Anticancer Res. 17, 987-993.
14. Houseknecht, K.L., Vanden Heuvel, J.P., Moya-Camarena, S.Y., Portocarrero, C.P., Peck, L.W., Nickel, K.P., and Belury, M.A. (1998) Dietary Conjugated Linoleic Normalizes Impaired Glucose Tolerance in the Zucker Diabetic Fatty fa/fa Rat, Biochem. Biophys. Res. Commun. 244, 678-682.
15. Ha, Y.L., Storkson, J., and Pariza, M.W. (1990) Inhibition of Benzo(a)pyrene-Induced Mouse Forestomach Neoplasia by Conjugated Dienoic Derivatives of Linoleic Acid, Cancer Res. 50, 1097-1101.
16. Park, Y., Storkson, J.M., Albright, K.J., Liu, W., and Pariza, M.W. (1999) Evidence That the trans-10,cis-12 Isomer of Conjugated Linoleic Acid Induces Body Composition Changes in Mice, Lipids 34, 235-241.
17. de Deckere, E.A., van Amelsvoort, J.M., McNeill, G.P., and Jones, P. (1999) Effects of Conjugated Linoleic acid (CLA) Isomers on Lipid Levels and Peroxisome Proliferation in the Hamster, Br. J. Nutr. 82, 309-317.
18. Munday, J.S., Thompson, K.G., and James, K.A. (1999) Dietary Conjugated Linoleic Acids Promote Fatty Streak Formation in the C57BL/6 Mouse Atherosclerosis Model, Br. J. Nutr. 81, 251-255.
19. Stangl, G.I. (2000) Conjugated Linoleic Acids Exhibit a Strong Fat-to-Lean Partitioning Effect, Reduce Serum VLDL Lipids and Redistribute Tissue Lipids in Food-Restricted Rats, J. Nutr. 130, 1140-1146.
20. Gavino, V.C., Gavino, G., Leblanc, M.J., and Tuchweber, B. (2000) An Isomeric Mixture of Conjugated Linoleic Acids but Not Pure cis-9, trans-11-Octadecadienoic Acid Affects Body Weight Gain and Plasma Lipids in Hamsters, J. Nutr. 130, 27-29.
21. Nicolosi, R.J., Wilson, T.A., Rogers, E.J., and Kritchevsky, D. (1998) Effects of Specific Fatty Acids (8:0, 14:0, cis-18:1, trans-18:1) on Plasma Lipoproteins, Early Atherogenic Potential, and LDL Oxidative Properties in the Hamster, J. Lipid Res. 39, 1972-1980.
22. Leung, Y.H., and Liu, R.H. (2000) Trans-10,cis-12-Conjugated Linoleic Acid Isomer Exhibits Stronger Oxyradical Scavenging Capacity Than cis-9,trans-11-Conjugated Linoleic Acid Isomer, J. Agric. Food Chem. 48, 5469-5475.
23. Van den Berg, J.J.M., Cook, N.E., and Tribble, D.L. (1995) Reinvestigation of the Antioxidant Properties of Conjugated Linoleic Acid, Lipids 30, 599-605.
24. Ulf, R., Samar, B., Stefan, J., Gunilla, N.F., Johan, A., and Bengt, V. (2002) Supplementation with Conjugated Linoleic Acid Causes Isomer-Dependent Oxidative Stress and Elevated C-Reactive Protein, Circulation 106, 1925-1929.
25. Wilson, T.A., Nicolosi, R.J., Chrysam, M., and Kritchevsky, D. (2000) Conjugated Linoleic Acid Reduces Early Aortic Atherosclerosis to a Greater Degree Than Linoleic Acid in Hypercholesterolemic Hamsters, Nutr. Res. 20, 1795-1805.
26. Nicolosi, R.J., Wilson, T.A., Handelman, G., Foxall, T., Keaney, J.F., and Vita, J.A. (2002) Decreased Aortic Early Atherosclerosis in Hypercholesterolemic Hamsters Fed Oleic Acid-Rich TriSun Oil Compared to Linoleic Acid-Rich Sunflower Oil, J. Nutr. Biochem. 13, 392-402.
27. Park, Y., Albright, K.J., Storkson, J.M., Liu, W., Cook, M.E., and Pariza, M.W. (1999) Changes in Body Composition in Mice During Feeding and Withdrawal of Conjugated Linoleic Acid, Lipids 34, 243-248.
28. Berliner, J.A., Navab, M., Fogelman, A.M., Frank, J.S., Demer, L.L., Edwards, P.A., Watson, A.D., and Lusis, A.J. (1995) Atherosclerosis: Basic Mechanisms. Oxidation, Inflammation, and Genetics, Circulation 91, 2488-2496.
29. Mackness, B., Davies, G. K., Turkie, W., Lee, E., Roberts, D.H., Hill, E., Roberts, C., Durrington, P.N., and Mackness, M.I. (2001) Paraoxonase Status in Coronary Heart Disease: Are Activity and Concentration More Important Than Genotype? Arterioscler. Thromb. Vasc. Biol. 21, 1451-1457.
30. Mackness, B., Durrington, P.N., and Mackness, M.I. (2002) The Paraoxonase Gene Family and Coronary Heart Disease, Curr. Opin. Lipidol. 3, 357-362.
31. Aviram, M., Hardak, E., Vaya, J., Mahmood, S., Milo, S., Hoffman, A., Billicke, S., Draganov, D., and Rosenblat, M. (2000) Human Serum Paraoxonase (PON1) Q and R Selectively Decrease Lipid Peroxides in Human Coronary and Carotid Atherosclerotic Lesions: PON1 Esterase and Peroxidase-Like Activities, Circulation 101, 2510-2517.
32. Aviram, M., Rosenblat, M., Billecke, S., Erogul, J., Sorenson, R., Bisgaier, C., Newton, R.S., and La Du, B.N. (1999) Human Serum Paraoxonase (PON 1) Is Inactivated by Oxidized Low Density Lipoprotein and Preserved by Antioxidants, Free Radic. Biol. Med. 26, 892-904.
33. Nguyen, S.D., Kim, J.R., Jeong, T.S., Liu, X.-W., and Sok, D.-E. (2002) Oxidative Inactivation of Paraoxonase from Human Plasma, J. Pharm. Sci. (C.N.U.) 17, 40-45.
34. Oda, M.N., Bielicki, J.K., Berger, T., and Forte, T.M. (2001) Cysteine Substitutions in Apolipoprotein A-I Primary Structure Modulate Paraoxonase Activity, Biochemistry 40, 1710-1718.
35. Kuo, C.-L., and La Du, B.N. (1995) Comparison of Purified Human and Rabbit Serum Paraoxonases, Drug Metab. Dispos. 23, 935-944.
36. Kudchodkar, B.J., Lacko, A.G., Dory, L., and Fungwe, T.V. (2000) Dietary Fat Modulates Serum Paraoxonase 1 Activity in Rats, J. Nutr. 130, 2427-2433.
37. Gan, K.N., Smolen, A., Eckerson, H.W., and La Du, B.N. (1991) Purification of Human Serum Paraoxonase/Arylesterase: Evidence for One Esterase Catalyzing Both Activities. Drug Metab. Dispos. 19, 100-106.
38. Sorenson, R.C., Aviram, M., Bisgaier, C.L., Billecke, S., Hsu, C., and La Du, B.N. (1999) Properties of the Retained N-Terminal Hydrophobic Leader Sequence in Human Serum Paraoxonase/Arylesterase, Chem. Biol. Interact. 119-120, 243-249.
39. Ahmed, Z., Ravandi, A., Maguire, G.F., Emili, A., Draganov, D., La Du, B.N., Kuksis, A., and Connelly, P.W. (2001) Apolipoprotein A-I Promotes the Formation of Phosphatidylcholine Core Aldehydes That Are Hydrolyzed by Paraoxonase (PON-1) During High Density Lipoprotein Oxidation with a Peroxynitrite Donor. J. Biol. Chem. 276, 24473-24481.
40. Sangvanich, P., Mackness, B., Gaskell, S.J., Durrington, P., and Mackness, M. (2003) The Effect of High-Density Lipoproteins on the Formation of Lipid/Protein Conjugates During in vitro Oxidation of Low-Density Lipoprotein, Biochem. Biophys. Res. Commun. 300, 501-506.
41. Maor, L., Hayek, T., Coleman, R., and Aviram, M. (2000) Plasma LDL Oxidation Leads to Its Aggregation in the Atherosclerotic Apolipoprotein E-Deficient Mice, Arterioscler. Thromb. Vasc. Biol. 17, 2995-3005.
42. Ayub, A., Mackness, M.I., Arrol, S., Mackness, B., Patel, J., and Durrington, P.N. (1999) Serum Paraoxonase After Myocardial Infarction. Arterioscler. Thromb. Vasc. Biol. 17, 2995-3005.
43. Josse, D., Xie, W., Renault, F., Rohu, D., Schopfer, L.M., Masson, P., and Lockridge, O. (1999) Identification of Residues Essential for Human Paraoxonase (PON1) Arylesterase/Organophosphatase Activities, Biochemistry 38, 2816-2825.
44. Awad, A.B., Begdache, L.A., and Fink, C.S. (2000) Effect of Sterols and Fatty Acids on Growth and Triglyceride Accumulation in 3T3-L1 cells, J. Nutr. Biochem. 11, 153-158.
45. Scheffer, P.G., Bakker, S.J.L., Popp-Snijders, C., Heine, R.J., Schutgens, R.B.H., and Teerlink, T. (2001) Composition of LDL as Determinant of Its Susceptibility to in vitro Oxidation in Patients with Well-Controlled Type 2 Diabetes, Diabetes Metab. Res. Rev. 17, 459-466.